Chronic Kidney Disease Prevention
Chronic Kidney Disease Prevention
This page is deliberately narrow. Chronic kidney disease cannot be prevented by a diet, a supplement or a detox, and any page claiming otherwise is selling something. What is preventable is more limited and more valuable: the conditions that cause it, the acceleration once it exists, and the deteriorations that catch people by surprise. That is what follows — who should be tested, what protects remaining function, and what a monitoring plan actually contains.
What prevention honestly means here
Three things are preventable, and it is worth separating them because they are often blurred together.
The causes. Diabetes and high blood pressure account for most chronic kidney disease, and both are detectable early, treatable, and in the case of type 2 diabetes substantially preventable. Preventing them prevents the kidney disease that follows — which is the largest effect available and happens years before any kidney test is abnormal.
The acceleration. Once the disease exists, the rate of decline is not fixed. Uncontrolled blood pressure, ongoing protein leak, smoking, and repeated episodes of acute injury each steepen the slope, and each is addressable. This is the part of prevention that applies to someone who already has the diagnosis, and it is where most of the remaining benefit sits.
The complications. Anaemia, bone disease, acidosis and fluid overload are consequences rather than inevitabilities. They are found by measuring them and treated when found, and they account for a large share of what makes advanced disease hard to live with.
And one thing is not preventable at all: function that has already been lost does not return. Stating that plainly is what makes the rest of the page worth reading, because everything below is aimed at what remains.
Who should be tested, and what the test is
Testing is aimed at the groups in which the disease is common enough and silent enough to be worth finding. That means anyone with diabetes, anyone with treated or untreated high blood pressure, anyone with established cardiovascular disease, anyone with a family history of kidney failure or polycystic kidney disease, anyone with recurrent stones or urinary obstruction, and anyone taking medicines with a known kidney effect long-term.
The test is two measurements, and the second is the one that gets omitted. A blood creatinine with an estimated filtration rate, and a urine albumin-to-creatinine ratio on a single sample. Both are cheap, both are widely available, and — because the disease is silent — they are the only way it gets found at a stage where anything can be done. A kidney ultrasound is added where obstruction, asymmetry or a cystic disease is suspected, and where the picture suggests it.
How often is set by the stage rather than by a calendar rule: annually for most at-risk groups, more often once an abnormality has appeared, and at intervals agreed with the team as the stage advances. The pattern of results over time is the point, which is why the same two measurements repeated on a schedule are more valuable than a wider panel done once.
What protects the function that remains
The list is short, unglamorous and effective. None of it is new information to anyone who has managed a long-term condition; what is specific here is that each item acts on the slope of this particular disease.
| Measure | What it protects against | How much it asks |
|---|---|---|
| Blood pressure to target | The strongest driver of decline, and the protein leak that follows it | Daily medicines, home readings, and salt reduction — the largest effect for the least novelty |
| Not smoking | Vascular damage shared by the kidney and the heart | The single most valuable change available at every stage |
| Salt reduction | Fluid retention, blood pressure, and the workload on the filter | Mostly a matter of where food comes from rather than of a salt cellar |
| Sick-day rules | Acute injury during vomiting, diarrhoea or reduced drinking, which can cost years in days | A written plan, agreed in advance, saying which medicines to pause and when to seek help |
| Regular activity | Cardiovascular risk, blood pressure, and the fatigue of the disease | Moderate and sustained, with practical adjustments for dialysis access and cystic disease |
The medicines question, and what to ask about
Medicines are both the most effective protection in this disease and one of its commonest causes of sudden harm, and the same conversation covers both.
On the protective side: the medicines discussed on the treatment page — the agents that lower pressure inside the filtering unit, and the SGLT2 inhibitors — are taken consistently rather than only when a reading is high, because a substantial part of their benefit is not about the number. Stopping them because the blood pressure looks normal is one of the commonest self-inflicted setbacks we see.
On the harmful side: the group most often responsible is non-steroidal anti-inflammatory painkillers, including combination cold remedies and some topical products. The risk is not from a single dose in a healthy person but from regular use, or from use during an illness when fluid intake has fallen. Other medicines that need thought include some antibiotics, contrast agents used for imaging, and long-term acid-suppressing medicines.
What to do about it is simple and worth doing once, properly: keep a written list of everything taken, including supplements, herbal products and anything bought without a prescription; take it to every appointment; and ask specifically whether each item is safe for the kidneys at the current stage. The question is not whether a medicine is dangerous in general but whether it is right for this person at this stage, and that is a question the team can answer in a minute.
What a monitoring plan contains
Monitoring exists because the trend is the only thing that reveals whether the plan is working, and a trend cannot be reconstructed from memory. The plan is written down, and it has four parts.
What is measured, and how often — filtration rate and urine albumin at intervals set by the stage; blood pressure at home; and the chemistry of the complications — haemoglobin, calcium, phosphate, parathyroid hormone, bicarbonate and potassium — once those are in range for monitoring rather than waiting for symptoms.
What each result would trigger — a fall in filtration rate beyond an agreed amount, a rise in albumin, a potassium above an agreed threshold. Thresholds written in advance turn a result into an action rather than into a worry.
What happens during illness — the sick-day plan, which medicines are paused, and when to seek assessment. This is the part that prevents acute injury, and it is the part most often missing from a file.
What the future looks like — at stage G4, education about the forms of kidney replacement, and the preparation of vascular access or a peritoneal catheter while the person still feels well. Prepared at leisure, the transition is a choice. Prepared in a crisis, it is an emergency, and the outcomes differ.